hep global Increases Revenue and EBIT in the First Half of 2026

hep global’s first-half 2026 revenue rose 72% to EUR 17.2 million, and EBIT returned to positive territory at EUR 0.3 million from a EUR 2.4 million loss; net loss narrowed to EUR 3.8 million from EUR 6.8 million. However, the company lowered its 2026 revenue outlook to EUR 40–45 million from EUR 45–55 million and now expects EBIT of EUR 1–5 million, citing margin pressure and postponed project transactions amid refinancing needs. Project development revenue increased to EUR 14.7 million from EUR 6.8 million, while the company continues to prioritize cost discipline and its core development business.

Analysis

The key signal is not the return to positive EBIT but the gap between accounting progress and cash conversion. Higher work in progress and delayed project transactions suggest value is accumulating in projects that have not yet become liquidity; the pending green-bond refinancing is therefore a potential constraint on realizing that value, not a peripheral financing issue. The reduced revenue outlook despite stronger first-half activity reinforces that execution and transaction timing—not simply project demand—are binding.

The revised range implies EUR 22.8–27.8m of second-half revenue, versus EUR 17.2m in the first half: a meaningful acceleration is needed. The remaining EBIT requirement is EUR 0.7–4.7m, so the top end depends on both transaction completion and margin resilience. The operating-cost reductions are supportive, but do not establish that project economics or cash generation are durable.

Near term, expect financing terms and liquidity disclosures to dominate the equity narrative. Over 1–3 months, refinancing progress and evidence that postponed sales close are the catalysts; over 6–18 months, the shift away from services could improve focus but also removes recurring revenue, increasing dependence on lumpy development monetizations. The contrarian point: a lower cost base can make reported EBIT look healthier while refinancing and delayed cash receipts still leave the business vulnerable. Verify cash, net debt, bond covenants and refinancing terms before treating the EBIT inflection as a de-risking event.

Key Decisions for Investors

• Maintain a cautious stance on hep global’s equity; the operating inflection is not yet a cash-flow inflection. Avoid sizing a bullish position off first-half EBIT alone.
• For credit exposure, require a clear refinancing update and review liquidity, covenant headroom, maturity terms and any collateral or dilution implications before adding risk. The article does not provide enough detail to price the bond risk confidently.
• Track the next disclosures for project-sale closures, cash conversion and second-half revenue cadence. Failure to convert the required EUR 22.8–27.8m of second-half revenue, or further transaction deferrals, would falsify the recovery case and raise downside risk.
• Treat the service-business exits as a watch item: confirm sale proceeds, transition costs and the recurring revenue lost. The strategic focus may help margins, but could increase earnings volatility if development transactions remain lumpy.